This is a copy of the May 19th edition of our weekly Newsletter, which we have been publishing since October 2015.
With 19 conference calls confirmed by the New Cannabis Ventures Earnings Calendar Wednesday through Friday and possibly a hundred filings in total between now and the 30th, the deadline, we think it’s going to be challenging to stay on top of things. With that in mind, we want to share some things we’ll be hoping to learn.
With its impressive Q1, GW Pharma moved to the top of the Public Cannabis Company Revenue Tracker for companies reporting in U.S. dollars at $39.2 million, but we expect it will be surpassed. Trulieve had held the top spot, and it is expected to report sales of about $42 million due to more store openings in Florida. Another company that could move past GW Pharma is Curaleaf Holdings, which is expected to have generated revenue of $38 million. Beyond revenue levels and growth of the leaders and others, we also expect that investors will be focused beyond the top-line to see progress in financial performance as the multi-state operators scale up their operations.
With MedMen moving this past week to an all-time low despite finalizing the first $100 million tranche of its $250 million financing with Gotham Green Partners, we think this will be one of the most important calls of the week. The company has moved to address investor concerns about what has been perceived to be excessive spending, and this will be an opportunity for the company and its new CFO to demonstrate viability going forward.
Finally, several of the companies hosting calls this week are in the middle of substantial mergers/acquisitions, and we think investors will be looking forward to updates on the timing of the closes and additional information about the planning these companies have been doing, which include Acreage Holdings, Cresco Labs, Curaleaf, Green Thumb Industries, Harvest Health and Recreation and MedMen.
While Indiva is currently serving medical patients and the Ontario retail market with pre-rolls, it will soon launch oils under the current rules and expects to expand distribution to other provinces. More importantly, though, Indiva has positioned for the next phase of the adult-use market, which will permit branded products, including vape pens and edibles. The company has exclusive rights to the Bhang brand in Canada and to the IP and distribution of the unique sugar and salt products from Deepcell Industries. Additionally, the company remains on track to complete its 70 metric ton ethanol extraction system.
To learn more about Indiva Limited, a client of New Cannabis Ventures, visit the company’s Investor Dashboard that we maintain on its behalf and click the blue Follow Company button in order to stay up to date with their progress.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:
- Canadian LP Flowr Approved for NASDAQ Listing
- Canopy Growth Appoints Constellation Brands Veteran as New CFO
- Canopy Growth Buys Global Skincare Company This Works for $74 Million
- Exclusive: Early Mover Hyasynth Bio Aims to Deliver in the Cannabinoid Biosynthesis Space
- Gotham Green Completes Initial $100 Million Tranche of the MedMen Secured Convertible Loan
- Green Thumb Industries Raises $105 Million through Debt with Warrants
- Horizons Introduces New Cannabis ETFs for Leveraged and Inverse Sector Exposure
- TerrAscend Generates Q1 Revenue of $14.6 Million and Reiterates 2019 Guidance of $135 Million
- Exclusive: Top 33 Revenue Generating Cannabis Stocks Ranked as of May 17th
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.
View the Public Cannabis Company Revenue Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than $5 million per quarter.
Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.
Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.
Consider subscribing to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013 for more in-depth information and market intelligence about the publicly traded cannabis sector.
Find your place in the cannabis industry by visiting our Careers and Jobs Page and learn which companies are hiring aggressively.
Alan & Joel